1 Min Read
Aug 6 (Reuters) - Sangui Biotech International Inc : * Says start of preclinical trials to certify an oxygen carrier as a Class III medical product Source text for Eikon * Further company coverage
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.